Published in Cancer Weekly, August 6th, 2002
The cyclooxygenase (COX)-2 enzyme has been indicted in breast, pancreas, lung, and colon cancer formation, and has been linked to tumor angiogenesis, or neovascularization in some cancers. Medical researchers in Japan have reported that elevated levels of COX-2 can be found in tissues remaining after gastric cancer resection, signaling a role for COX-2 inhibitors in stopping the development of remnant gastric cancers.
"It is well known that the gastric remnant is at greater risk for the development of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.